ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
Here are 3 of my top ethical ETFs for Australian investors in 2021. BetaShares Global Sustainability Leaders ETF (ASX: ETHI), eInvest Future Impact Small Caps Fund (ASX: IMPQ) and Vanguard Ethically Conscious International Shares Index ETF (ASX: VESG).
ResMed CDI (ASX:RMD) shares have a long history of outperformance and delivering impressive returns for its shareholders. Is it too late to buy ResMed shares?
The S&P/ASX 200 (ASX: XJO) is expected to trade higher on Monday morning, according to data from the Sydney Futures Exchange. ResMed Inc (ASX:RMD) and AMP Ltd (ASX:AMP) shares are in focus.
The S&P/ASX 200 (INDEXASX: XJO) is expected to edge lower when the market opens this morning. Myer (ASX: MYR), Nick Scali (ASX: NCK) and ResMed (ASX: RMD) shares are making headlines.
The ResMed Inc (ASX:RMD) profit jumped 40% in its FY20 result due to high ventilator demand. The ResMed share price is expected to open lower.
The Avita Therapeutics Inc (ASX: AVH) share price was trading 10.53% lower today following an investor update to do with its BARDA partnership.
The All Ordinaries (ASX: XAO) is 3.8% in the red on Friday.
The ResMed (ASX:RMD) share price is up around 5% despite the ASX having a fairly rough day. It announced its third quarter update.
The Cochlear Limited (ASX: COH) share price was trading 19.25% lower today following the release of news it would suspend its profit guidance for FY20.
